BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12393650)

  • 1. Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.
    Deaglio S; Capobianco A; Calì A; Bellora F; Alberti F; Righi L; Sapino A; Camaschella C; Malavasi F
    Blood; 2002 Nov; 100(10):3782-9. PubMed ID: 12393650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.
    Fleming RE; Migas MC; Holden CC; Waheed A; Britton RS; Tomatsu S; Bacon BR; Sly WS
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2214-9. PubMed ID: 10681454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of 111In-labeled fully human monoclonal antibody TSP-A18 reflects transferrin receptor expression in normal organs and tissues of mice.
    Sugyo A; Tsuji AB; Sudo H; Nomura F; Satoh H; Koizumi M; Kurosawa G; Kurosawa Y; Saga T
    Oncol Rep; 2017 Mar; 37(3):1529-1536. PubMed ID: 28184946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo.
    Panaccio M; Zalcberg JR; Thompson CH; Leyden MJ; Sullivan JR; Lichtenstein M; McKenzie IF
    Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():461-72. PubMed ID: 2452131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
    Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
    Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin receptor activity and localisation in the rat duodenum.
    Oates PS; Thomas C; Morgan EH
    Pflugers Arch; 2000 May; 440(1):116-24. PubMed ID: 10864004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody.
    Kissel K; Hamm S; Schulz M; Vecchi A; Garlanda C; Engelhardt B
    Histochem Cell Biol; 1998 Jul; 110(1):63-72. PubMed ID: 9681691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding properties of monoclonal antibody to the cytoplasmic domain of transferrin receptor.
    Yoshimori T; Shimonishi Y; Uchida T
    Cell Struct Funct; 1988 Aug; 13(4):311-24. PubMed ID: 3180258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism for multiple ligand recognition by the human transferrin receptor.
    Giannetti AM; Snow PM; Zak O; Björkman PJ
    PLoS Biol; 2003 Dec; 1(3):E51. PubMed ID: 14691533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.
    Daniels TR; Delgado T; Rodriguez JA; Helguera G; Penichet ML
    Clin Immunol; 2006 Nov; 121(2):144-58. PubMed ID: 16904380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.
    Lebrón JA; West AP; Bjorkman PJ
    J Mol Biol; 1999 Nov; 294(1):239-45. PubMed ID: 10556042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface.
    Giannetti AM; Björkman PJ
    J Biol Chem; 2004 Jun; 279(24):25866-75. PubMed ID: 15056661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression.
    Ishiguro K; Ho PT; Sartorelli AC
    Somat Cell Mol Genet; 1992 Jan; 18(1):45-63. PubMed ID: 1546369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease.
    Suzuki Y; Saito H; Suzuki M; Hosoki Y; Sakurai S; Fujimoto Y; Kohgo Y
    Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):26S-31S. PubMed ID: 12198371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
    Ul-Haq R; Chitambar CR
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.
    Qing Y; Shuo W; Zhihua W; Huifen Z; Ping L; Lijiang L; Xiaorong Z; Liming C; Daiwen X; Yu H; Wei X; Min F; Zuohua F; Guanxin S
    Cancer Immunol Immunother; 2006 Sep; 55(9):1111-21. PubMed ID: 16341531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transferrin receptor and iron deposition pattern in the hepatic lobules of the iron-deficient and iron-overloaded rats].
    Lu J; Hayashi K; Hu X
    Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):75-7. PubMed ID: 7788730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin and transferrin receptors update.
    Kawabata H
    Free Radic Biol Med; 2019 Mar; 133():46-54. PubMed ID: 29969719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin and transferrin receptor in human hypophysis and pituitary adenomas.
    Tampanaru-Sarmesiu A; Stefaneanu L; Thapar K; Kontogeorgos G; Sumi T; Kovacs K
    Am J Pathol; 1998 Feb; 152(2):413-22. PubMed ID: 9466567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
    Sugyo A; Tsuji AB; Sudo H; Nagatsu K; Koizumi M; Ukai Y; Kurosawa G; Zhang MR; Kurosawa Y; Saga T
    Nucl Med Commun; 2015 Mar; 36(3):286-94. PubMed ID: 25460304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.